Markets

Don't Make it Complicated, Own Drug Stocks

In mid-June, the 15-company strong Large Cap Pharma industry held a Zacks Industry Rank of 44 out of 265 (that's the top 17%). In recent weeks, covering analysts made 10 positive earnings estimate revisions and just 5 negative revisions to large cap drug stocks. Broad, top-down tailwinds like this? I see them nearly every time I look into the pharma industry. Furthermore, each time I write up the Zacks Monthly Market Strategy investor report, the Health Care sector lands in the top 3 or 4 attractive spots out of the 10 S&P500 sectors. No other S&P500 sector is as consistently ranked so favorably.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BRISTOL-MYERS (BMY): Free Stock Analysis Report

PFIZER INC (PFE): Free Stock Analysis Report

H LUNDBECK A S (HLUYY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

HLUYY BMY PFE

Other Topics

Stocks

Latest Markets Videos